Challenges in immunogenicity assessments for biosimilar development
The biosimilar market is rapidly growing across the globe as patents and exclusivities for biologic products approach their expiration dates. Indeed, biosimilars offer more access due to their affordability which is a key driving factor for market development, particularly in emerging markets with growing economies. However, biosimilar development is prone to many challenges, through all […]
Challenges in immunogenicity assessments for biosimilar development Read More »